| |
THURSDAY,
JANUARY
24TH |
FRIDAY, JANUARY 25TH |
SATURDAY, JANUARY 26TH |
SUNDAY, JANUARY 27TH |
| 08:00
- 10:00 | |
THE ROLE OF CHOLINESTERASE INHIBITION
IN THE TREATMENT OF VASCULAR DEMENTIA Sponsored
by Eisai Inc and Pfizer Inc Hall
A |
DRUG STUDIES
Hall A
|
IMAGING
Hall B |
SESSION TITLE
TO BE ADVISED
Hall
C | WHITE
MATTER Hall A |
IMAGING II Hall
B | MECHANISMS
Hall C
| RISK
FACTORS Hall D |
| 10:00
- 10:30 |
| COFFEE
BREAK & POSTER VIEWING |
|
10:30 - 12:30 |
| REFINING
TREATMENT OPTIONS IN DEMENTIA
Sponsored by Janssen-Cilag Hall
A | 10:30
– 11:30 SUBCORTICAL VASCULAR
DEMENTIA – A HOMOGENOUS DISEASE ENTITY? Hall
A | 10:30
– 11:30 VASCULAR FACTORS Hall
B | THERAPY Hall
A |
| 11:30
– 13:00 PREVENTION OF DEMENTIA
BY BLOOD PRESSURE CONTROL: METHODOLOGY AND RESULTS FROM MULTI-CENTER CLINICAL
TRIALS Hall A |
| 12:30 | |
L U N C H
Sponsored by Janssen-Cilag |
13:00 – 14:00 L
U N C H B R E A K |
12:35 – 13:30
CLOSING SESSION Hall
A |
|
14:00 - 16:00 |
16:30 REGISTRATION |
OPENING SESSION Hall
A | PROGRESS
IN GENETICS AND
FAMILIAR FORMS OF SMALL
VESSEL DISEASE
Hall A |
DIAGNOSIS Hall
B |
|
16:00 - 16:30 | |
COFFEE BREAK & POSTER VIEWING
|
| 16:30
- 18:30 | |
NEUROPSYCHOLOGY Hall
A | EPIDEMOLOGY Hall
B | PROGNOSIS Hall
C | VASCULAR
COGNITIVE IMPAIRMENT- TOWARDS CRITERIA
Hall D |
AGE-RELATED WHITE MATTER CHANGES
AND DISABILITY Hall A |
|
| 18:30 GET-
TOGETHER RECEPTION Sponsored
by
Eisai Inc and Pfizer Inc |
20:30
CONCERT |
20:30
FAREWELL DINNER (OPTIONAL) |
|
